Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome

By sjmartinez • October 5, 2022

Gaylis NB, Ritter A, Kelly SA, Pourhassan NZ, Tiwary M, Sacha JB, Hansen SG, Recknor C, Yang OO. Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome. Clin Infect Dis. 2022 Sep 30;75(7):1232-1234. doi: 10.1093/cid/ciac226. PMID: 35452519; PMCID: PMC9383814.

Tags: CCR5, immunosuppression, Infectious Diseases, leronlimab, long COVID, Publications

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureusBacteremia

Chan LC, Lee HK, Wang L, Wang H, Filler SG, Ciranna A, Abdelhady W, Xiong YQ, Li L, Gonzales RA, Ruffin F, Fowler VG Jr,[...]

Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083

Landovitz RJ, Fogel JM, Gao F, Hanscom B, Piwowar-Manning E, Moser A, Marzinke MA, Cyktor J, Seisa M, Halvas EK, Kofron R, Jennings A, Clement[...]

Immune activation from M. tuberculosis screening tests predicts mortality

Seligman B, Ganz DA, Goetz MB, Beenhouwer DO. Immune activation from M. tuberculosis screening tests predicts mortality. Geroscience. 2026 Apr 27. doi: 10.1007/s11357-026-02221-y. Epub ahead[...]